Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,040 | 72,640 | 76,963 | 82,228 | 85,401 |
| TOTAL | $68,148 | $72,821 | $77,219 | $82,256 | $85,495 |
| Non-Current Assets | |||||
| Investments And Advances | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
| Intangibles | 3,549 | 3,549 | 3,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 8 | 8 | 8 | 8 | 8 |
| TOTAL | $5,129 | $5,129 | $5,129 | $5,129 | $5,129 |
| Total Assets | $73,277 | $77,951 | $82,349 | $87,385 | $90,624 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 128 | 446 | 861 | 559 | 205 |
| Accrued Expenses | 458 | 382 | 450 | 530 | 499 |
| TOTAL | $587 | $828 | $1,311 | $1,089 | $704 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $587 | $828 | $1,311 | $1,089 | $704 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,778 | 17,443 | 18,727 | 20,750 | 20,749 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -115,959 | -115,838 | -115,074 | -113,194 | -111,649 |
| Other shareholders' equity | 416 | -272 | -491 | -105 | -16 |
| TOTAL | $72,690 | $77,123 | $81,038 | $86,296 | $89,920 |
| Total Liabilities And Equity | $73,277 | $77,951 | $82,349 | $87,385 | $90,624 |